Perspective Therapeutics (CATX) Non Operating Income (2010 - 2026)
Perspective Therapeutics (CATX) posted Non Operating Income of $2.1 million for Q1 2026, down 42.76% sequentially from $3.7 million in Q1 2025, and down 42.76% YoY from $3.7 million in Q1 2025.
Perspective Therapeutics (CATX) Non Operating Income (2010 - 2026) Analysis & Trends
Perspective Therapeutics has reported Non Operating Income for 17 years, with the latest figure at $2.1 million in Q1 2026.
- Quarterly Non Operating Income fell 42.76% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (down 7.4% YoY) and the FY2025 annual result came in at $9.1 million, down 12.65% from the prior year.
- Non Operating Income fell to $2.1 million in Q1 2026 per CATX's latest filing, from $3.7 million in the prior quarter.
- Over five years, Non Operating Income peaked at $3.7 million in Q1 2025 and troughed at $29000.0 in Q1 2022.
- A 5-year average of $1.3 million and a median of $458500.0 in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income plunged 94.12% in 2023, then jumped 8136.36% in 2024.
- Over 5 years, Non Operating Income stood at $561000.0 in 2022, then slumped by 94.12% to $33000.0 in 2023, then surged by 8136.36% to $2.7 million in 2024, then jumped by 34.47% to $3.7 million in 2025, then sank by 42.76% to $2.1 million in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $2.1 million, $3.7 million, and $2.7 million for Q1 2026, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Perspective Therapeutics | 387.28 Mn | 387.28 Mn | - | 2.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 2.09 Mn |
| Mar 31, 2025 | 3.66 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | 3.51 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 1.18 Mn |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 178,000.00 |
| Jun 30, 2023 | 268,000.00 |
| Mar 31, 2023 | 356,000.00 |
| Dec 31, 2022 | 561,000.00 |
| Sep 30, 2022 | 197,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Sep 30, 2021 | 31,000.00 |
| Mar 31, 2021 | 21,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 1,000.00 |